Journal of Dali University ›› 2021, Vol. 6 ›› Issue (8): 31-34.DOI: 10. 3969 / j. issn. 2096-2266. 2021. 08. 006
Previous Articles Next Articles
Bu Wei, Wang Yuhe, Gong Lei*
Received:
Revised:
Online:
Published:
Abstract: Objective: To evaluate the rationality of clinical use of ceftazidime and to provide reference for clinical standardization and rational use of ceftazidime. Methods: A total of 252 hospitalized patients who received ceftazidime injection were selected from July 2019 to September 2019 in the Affiliated Hospital of Zunyi Medical University (hereinafter referred to as “our hospital”). The rationality of medication was evaluated in terms of indications, dose regimen, microbiological examination, and combination of drugs. Results: The drugs of utilization index (DUI) of ceftazidime for injection in our hospital was < 1. Among the drug use of 252 cases, 214 cases (84.92%) were rational and 38 cases (15.08%) were irrational; 146 cases (57.94%) received routine etiological examinations, including 84 blood samples (57.53%) and 42 sputum samples (28.77%); 67 cases (26.59%) received combined use of the two drugs, and 1 case (0.40%) was incompatible. The patients used ceftazidime for injection were mainly hospitalized in the respiratory and critical medical area, involving respiratory diseases such as pneumonia and asthma, with a total number of 71 cases (28.18%). Conclusion: The clinical use of ceftazidime for injection in our hospital is basically rational, but there were still a few cases with inappropriate drug use.
Key words: inpatient, ceftazidime for injection, rational use of drug
CLC Number:
R969.3
Bu Wei, Wang Yuhe, Gong Lei. Evaluation of Rational Clinical Application of Ceftazidime for Injection in 252 Inpatients[J]. Journal of Dali University, 2021, 6(8): 31-34.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: http://journal15.magtechjournal.com/Jwk_dlxyzk/EN/10. 3969 / j. issn. 2096-2266. 2021. 08. 006
http://journal15.magtechjournal.com/Jwk_dlxyzk/EN/Y2021/V6/I8/31